Paeoniflorin alleviates high glucose-induced endothelial cell apoptosis in diabetes mellitus by inhibiting HRAS-activated RAS pathway
Paeoniflorin (Pae) can improve diabetes mellitus (DM), especially endothelial dysfunction induced by high glucose (HG). Molecularly, the mechanism pertinent to Pae and DM lacks further in-depth research. Hence, this study determined the molecular mechanism of Pae in treating DM through network pharm...
Saved in:
Main Authors: | Wenting Yu, Hongchun Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Endocrine Society
2024-11-01
|
Series: | Endocrine Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/endocrj/71/11/71_EJ24-0122/_html/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3
by: Yang Jianhui, et al.
Published: (2018-06-01) -
The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer
by: M. P. Smal, et al.
Published: (2015-12-01) -
Paeoniflorin alleviates sepsis-associated acute kidney injury in mice by inhibiting aerobic glycolysis through the β-catenin/c-Myc pathway
by: GONG Yu, et al.
Published: (2025-01-01) -
Klebsiella pneumoniae-derived extracellular vesicles impair endothelial function by inhibiting SIRT1
by: Xinxin Li, et al.
Published: (2025-01-01) -
Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus
by: Maja Preložnik Navodnik, et al.
Published: (2025-01-01)